10 POLISH BOOKS RELATING TO «OXELADIN»
Discover the use of
oxeladin in the following bibliographical selection. Books relating to
oxeladin and brief extracts from same to provide context of its use in Polish literature.
1
Consolidated List of Products Whose Consumption And/or Sale Have ...
(Reference: (DEURFI) Rapid Alert - Pharmacovigilance, , , 14 Mar 1995) FRA 19 Apr 1995 Since the results of the German study on the potential carcinogenicity of oxeladin were disseminated, the Medicinal Products Agency has recalled all ...
2
Hagers Handbuch der Pharmazeutischen Praxis: Band 8: Stoffe E-O
... mit ßß-Dichlordiethylether [Bis (2 Chlorethyl)ether] erfolgt im natronalkal Miheu Rkt zum a,a-Diphenylessigsaure 2-(ßchlorethoxy)-ethylester (4), der mit Diethylamin Oxeladin liefert Kle82 l CN + 2 C2H30| (1) (2) H502 Сгнз Na/NH3 fi __P CN ...
Franz v. Bruchhausen, Gerd Dannhardt, Siegfried Ebel, 2013
3
Pharmaceutical substances: syntheses, patents, applications
Oxeladin. ATC: R05DB09 Use: antitussive RN: 468-61-1 MF: C^HjjNOj MW: 335.49 EINECS: 207-418-4 LD»: 13 mg/kg (M, i.v.); 130 mg/kg (M, p.o.); 183mg/kg(R, p.o.) CN: a,a-diethylbenzeneacetic acid 2-[2-(diethylamino)ethoxy]ethyl ester ...
Axel Kleemann, Jürgen Engel, 2001
4
Český lékopis 2009 – Doplněk 2013: - Strona 9052
... peak identification Oxeladin-citrát Oxeladin hydrogen citrate Oxeladin nečistota C Oxeladin impurity C Oxeladin nečistota D Oxeladin impurity D Oxfendazol nečistota B Oxfendazole impurity B Oxfendazol pro veterinární použití Oxfendazole ...
Ministerstvo zdravotnictví ČR, 2013
5
Antitussive agents - Tom 2 - Strona 591
(c) Miscellaneous activity Large doses of oxeladin (larger than 0.1 mg/kg) produced reduction in amplitude of normal rhythmic contraction in the isolated rabbit duodenum. It has 1/600 of the activity of methantheline bromide against ...
Harry Salem, Domingo M. Aviado, 1970
6
Clarke's Isolation and Identification of Drugs in Pharmaceuticals, ...
Oxeladin Citrate Proprietary Names. Dorex-retard ; Paxeladine. C.oHjjNOj.QHjO^ 527.6 CAS— 52432-72-1 A white crystalline powder. M.p. 90° to 91°. Soluble in water. Colour Test. Marquis Test — orange. Thin-layer Chromatography.
Eustace George Coverley Clarke, A. C. Moffat, Pharmaceutical Society of Great Britain. Dept. of Pharmaceutical Sciences, 1986
7
Essentials of Pharmacology for Dentistry - Strona 284
Oxeladin Another synthetic centrally acting antitussive, devoid of opioid side effects. Chlophediano! It is similar to oxeladin, has a slow onset and longer duration of antitussive action. Side effect: Dryness of mouth, vertigo, irritability.
8
Ullmann's encyclopedia of industrial chemistry - Tom 11 - Strona 18
Trade Names. Atussil (Squibb), Gcrmapect (Thiemann), Sedotussin (UCB), Toclase (Pfizer, Sumitomo), Tuclase (UCB). Oxeladin [468-61-1], 2-(2-diethylamino- ethoxy)ethyl 3-phenyl-3-pentanecarboxylate, C20H33NO3, M, 335.47, bp 140 °C ...
Fritz Ullmann, Wolfgang Gerhartz, Y. Stephen Yamamoto, 1987
9
Pharmaceuticals: Neuropharmaceuticals, Gastrointestinal drugs, ...
sil (Squibb), Germapect (Thiemann), Sedotussin (UCB), Toclase (Pfizer. Sumitomo), Tuclase (UCB). Oxeladin [468-61-1], 2-(2-diethylaminoethoxy)ethyl 3-phenyl-3-pentanecarboxylate, C20H23NO3, M, 335.47, bp 140 °C ...
10
The Extra Pharmacopoeia: "Amendments" ( 2 l.) inserted - Strona 936
Oxeladin Citrate. 2-(2-Diethylaminoethoxy)ethyl diethylphenylacetate dihydrogen citrate. C,0HajOjN,C,H,O7= 527-6. Dose: 10 to 20 mg. (*/« to '/a grain) four times daily; 5 to 10 mg. ('/,, to '/6 grain) for children. Uses. Oxeladin is an antitussive ...